Showing results (2481-2490 of 2,573) with videos related to

Sort By:
Pageof 258
The Journal of Clinical Investigation|May 5, 2010
Hypoxia-inducible factor-1alpha regulates beta cell function in mouse and human isletsKim Cheng, Kenneth Ho, Rebecca Stokes, et al.
The Lancet. Oncology|January 6, 2018
Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working groupD Ross Camidge, Eudocia Q Lee, Nancy U Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2016
Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686)Chris Karlovich, Jonathan W Goldman, Jong-Mu Sun, et al.
Molecular Psychiatry|September 22, 2023
Tau suppresses microtubule-regulated pancreatic insulin secretionSalvatore P Mangiafico, Qing-Zhang Tuo, Xiao-Lan Li, et al.
Nature Genetics|July 18, 2018
Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosisKaarina Kowalec, Galen E B Wright, Britt I Drögemöller, et al.
American Journal of Respiratory and Critical Care Medicine|August 27, 2016
Age and Small Airway Imaging Abnormalities in Subjects with and without Airflow Obstruction in SPIROMICSCarlos H Martinez, Alejandro A Diaz, Catherine Meldrum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2019
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized StudyDaniel R Gomez, Chad Tang, Jianjun Zhang, et al.
The New England Journal of Medicine|June 4, 2013
Crizotinib versus chemotherapy in advanced ALK-positive lung cancerAlice T Shaw, Dong-Wan Kim, Kazuhiko Nakagawa, et al.
Neuro-Oncology|May 27, 2026
Breaking Barriers in Leptomeningeal Disease: A SNO-ASCO Consensus Review on Clinical Trial Design and Basic Science IntegrationYolanda Piña, Maxine Umeh Garcia, Adrienne Boire, et al.
The Lancet. Oncology|November 11, 2018
Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 studyBenjamin J Solomon, Benjamin Besse, Todd M Bauer, et al.
Pageof 258